Profile of Predictive Factors of Response to Therapy in Patients with Diffuse Large B-cell Lymphoma in dr Soetomo General Teaching Hospital Surabaya

• Main Authors: Mochammad Dilliawan, -, Siprianus Ugroseno Yudho Bintoro, -, Putu Niken Ayu Amrita, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Ektodermal Displazi Grubu 2020
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/109568/1/3.%20Profile%20of%20Predictive%20Factors%20of%20Response%20to%20Therapy%20in%20Patients%20with%20Diffuse%20Large%20B-cell.pdf; http://repository.unair.ac.id/109568/2/Profile%20of%20Predictive.pdf; http://repository.unair.ac.id/109568/3/Bukti%20Korespondensi%20Profile%20of%20Predictive.pdf; http://repository.unair.ac.id/109568/4/Profile%20of%20Predictive%20Factors%20of%20Response%20to%20Therapy%20in%20Patients%20with%20Diffuse%20Large%20B-cell%20Lymphooma%20in%20dr%20Soetomo%20General%20Teaching%20Hospital%20Surabaya.pdf; http://repository.unair.ac.id/109568/; http://www.jidmr.com/journal/wp-content/uploads/2020/06/67-M20_1102_Hendrik_Setia_Budi_Siprianus_U_Y_B_Indonesia.pdf

Despite the use of rituximab as a substantial treatment for Diffuse Large B-Cell Lymphoma (DLBCL), the survival rate remains low due to high incidences of relapse. Several predictive factors for relapse have been investigated however, still expensive and not applicable. Lymphocytemonocyte ratio (LMR...